[
  {
    "title": "佰仁医疗(688198.SH)：拟使用最高余额不超2亿元部分暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/12/05154337188719.shtml",
    "datetime": "2022-12-05 15:43:50",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：“昌平新城东区佰仁医疗二期建设项目”延期",
    "href": "http://stock.jrj.com.cn/2022/12/05154237188722.shtml",
    "datetime": "2022-12-05 15:42:15",
    "code": "688198"
  },
  {
    "title": "本周81家公司合计18.13亿股限售股解禁，祥生医疗、佰仁医疗等解禁压力大",
    "href": "http://stock.jrj.com.cn/2022/12/05083637187416.shtml",
    "datetime": "2022-12-05 08:36:43",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2022年前三季度净利5985.33万同比增长48.05% 主营业务销售收入增长",
    "href": "http://stock.jrj.com.cn/2022/10/25211137083321.shtml",
    "datetime": "2022-10-25 21:11:54",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：第三季度净利2255.46万元，同比增长60.31%",
    "href": "http://stock.jrj.com.cn/2022/10/25155337081614.shtml",
    "datetime": "2022-10-25 15:53:15",
    "code": "688198"
  },
  {
    "title": "佰仁医疗披露2022年半年报 实现营收1.41亿元",
    "href": "http://stock.jrj.com.cn/2022/08/29092836945561.shtml",
    "datetime": "2022-08-29 09:28:23",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198)：聘任公司高级管理人员",
    "href": "http://stock.jrj.com.cn/2022/08/29092036945578.shtml",
    "datetime": "2022-08-29 09:20:56",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)上半年净利3729.87万元，同比增长41.51%",
    "href": "http://stock.jrj.com.cn/2022/08/28161136944196.shtml",
    "datetime": "2022-08-28 16:11:20",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：65.8957万股归属限制性股票将上市流通",
    "href": "http://stock.jrj.com.cn/2022/07/21171436832392.shtml",
    "datetime": "2022-07-21 17:14:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗控股股东金磊增持8.13万股 增持金额997.54万 2021年公司净利5119.82万",
    "href": "http://stock.jrj.com.cn/2022/06/28201036765616.shtml",
    "datetime": "2022-06-28 20:10:35",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：实控人之一金磊完成增持8.129万股",
    "href": "http://stock.jrj.com.cn/2022/06/28154636764356.shtml",
    "datetime": "2022-06-28 15:46:17",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：控股股东金磊已累计增持2.55万股",
    "href": "http://stock.jrj.com.cn/2022/06/07173736709609.shtml",
    "datetime": "2022-06-07 17:37:57",
    "code": "688198"
  },
  {
    "title": "佰仁医疗（688198）：4月25日线上会议交流举行投资者关系活动",
    "href": "http://stock.jrj.com.cn/2022/06/01083836695451.shtml",
    "datetime": "2022-06-01 08:38:17",
    "code": "688198"
  },
  {
    "title": "A股异动 | 佰仁医疗(688198.SH)涨超5% 控股股东拟增持500万-1000万元股份",
    "href": "http://stock.jrj.com.cn/2022/05/31131336692688.shtml",
    "datetime": "2022-05-31 13:13:27",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：控股股东金磊拟增持500万元-1000万元股份",
    "href": "http://stock.jrj.com.cn/2022/05/30153936689463.shtml",
    "datetime": "2022-05-30 15:39:31",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)2021年年度权益分派10转4派5元 股权登记日5月25日",
    "href": "http://stock.jrj.com.cn/2022/05/19182036663055.shtml",
    "datetime": "2022-05-19 18:20:15",
    "code": "688198"
  },
  {
    "title": "快讯：佰仁医疗急速拉升10.16% 主力资金净流入1066.75万元(dev)",
    "href": "http://stock.jrj.com.cn/2022/05/11102136631135.shtml",
    "datetime": "2022-05-11 10:21:01",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2022年第一季度净利1360.69万同比增长53.54% 股份支付费用同比下降",
    "href": "http://stock.jrj.com.cn/2022/04/24215136450793.shtml",
    "datetime": "2022-04-24 21:51:34",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2021年净利5119.82万同比下滑9.42% 董事长金磊薪酬74万",
    "href": "http://stock.jrj.com.cn/2022/04/23051236434284.shtml",
    "datetime": "2022-04-23 05:12:26",
    "code": "688198"
  },
  {
    "title": "A股异动 | 佰仁医疗(688198.SH)涨超6% 一季度净利润1360.69万元 同比增长53.54%",
    "href": "http://stock.jrj.com.cn/2022/04/22105136427064.shtml",
    "datetime": "2022-04-22 10:51:12",
    "code": "688198"
  },
  {
    "title": "佰仁医疗披露2022年一季报 实现营收6600.56万元",
    "href": "http://stock.jrj.com.cn/2022/04/22090936425990.shtml",
    "datetime": "2022-04-22 09:09:03",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)一季度净利润1360.69万元 同比增长53.54%",
    "href": "http://stock.jrj.com.cn/2022/04/21194836421436.shtml",
    "datetime": "2022-04-21 19:48:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)2021年度净利降9.42%至5119.82万元 拟10派5元",
    "href": "http://stock.jrj.com.cn/2022/04/21194536421444.shtml",
    "datetime": "2022-04-21 19:45:20",
    "code": "688198"
  },
  {
    "title": "A股异动 | 佰仁医疗(688198.SH)5个月股价腰斩 2021年度净利润降6.93%",
    "href": "http://stock.jrj.com.cn/2022/02/22103334433545.shtml",
    "datetime": "2022-02-22 10:33:05",
    "code": "688198"
  },
  {
    "title": "剔除股份支付影响后，佰仁医疗去年盈利1.18亿元",
    "href": "http://stock.jrj.com.cn/2022/02/22102934433523.shtml",
    "datetime": "2022-02-22 10:29:54",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2021年净利5260.7万 较上年同期下滑6.93%",
    "href": "http://stock.jrj.com.cn/2022/02/21221134424152.shtml",
    "datetime": "2022-02-21 22:11:50",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)业绩快报：2021年度净利润降6.93%至5260.7万元",
    "href": "http://stock.jrj.com.cn/2022/02/21185734423487.shtml",
    "datetime": "2022-02-21 18:57:23",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：拟使用不超3亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/12/06154533973702.shtml",
    "datetime": "2021-12-06 15:45:56",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：120万股限售股将于12月9日解禁上市",
    "href": "http://stock.jrj.com.cn/2021/11/30180933945107.shtml",
    "datetime": "2021-11-30 18:09:43",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)第三季度净利润1406.89万元 同比增长23.05%",
    "href": "http://stock.jrj.com.cn/2021/10/27180333762866.shtml",
    "datetime": "2021-10-27 18:03:50",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：拟于11月18日召开2021年第二次临时股东大会",
    "href": "http://stock.jrj.com.cn/2021/10/27170133762669.shtml",
    "datetime": "2021-10-27 17:01:55",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：聘任程琪为公司财务总监",
    "href": "http://stock.jrj.com.cn/2021/09/14211533435503.shtml",
    "datetime": "2021-09-14 21:15:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗聘任程琪为公司财务总监 上半年公司净利2635.79万",
    "href": "http://stock.jrj.com.cn/2021/09/14182533434875.shtml",
    "datetime": "2021-09-14 18:25:51",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2021年上半年净利2635.79万下滑20.57% 销售费用增长",
    "href": "http://stock.jrj.com.cn/2021/08/16100633258784.shtml",
    "datetime": "2021-08-16 10:06:36",
    "code": "688198"
  },
  {
    "title": "增收不增利！佰仁医疗今年上半年盈利同比下滑超两成",
    "href": "http://stock.jrj.com.cn/2021/08/16094633258680.shtml",
    "datetime": "2021-08-16 09:46:15",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)半年度净利润2635.79万元 同比下降20.57%",
    "href": "http://stock.jrj.com.cn/2021/08/15162633253786.shtml",
    "datetime": "2021-08-15 16:26:28",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：向52名激励对象授予30万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/07/15173933102454.shtml",
    "datetime": "2021-07-15 17:39:46",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：介入式主动脉瓣系统临床试验完成备案",
    "href": "http://stock.jrj.com.cn/2021/06/18092132952509.shtml",
    "datetime": "2021-06-18 09:21:18",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：介入式主动脉瓣系统(TAVR)临床试验完成备案",
    "href": "http://stock.jrj.com.cn/2021/06/17164832948107.shtml",
    "datetime": "2021-06-17 16:48:43",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：在研产品介入式瓣中瓣系统临床试验备案",
    "href": "http://stock.jrj.com.cn/2021/05/24180532811585.shtml",
    "datetime": "2021-05-24 18:05:06",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：介入式瓣中瓣系统临床试验完成备案",
    "href": "http://stock.jrj.com.cn/2021/05/24171932811191.shtml",
    "datetime": "2021-05-24 17:19:29",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)2020年度权益分派10派2元 股权登记日为5月26日",
    "href": "http://stock.jrj.com.cn/2021/05/19164432782105.shtml",
    "datetime": "2021-05-19 16:44:55",
    "code": "688198"
  },
  {
    "title": "产品覆盖三大领域 佰仁医疗去年盈利同比下滑一成",
    "href": "http://stock.jrj.com.cn/2021/04/22113332422151.shtml",
    "datetime": "2021-04-22 11:33:42",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2021年第一季度净利886万元下滑1.12% 营业成本增加",
    "href": "http://stock.jrj.com.cn/2021/04/22101232421667.shtml",
    "datetime": "2021-04-22 10:12:48",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2020年净利下滑10.4% 董事长金磊薪酬74.46万",
    "href": "http://stock.jrj.com.cn/2021/04/22101132421634.shtml",
    "datetime": "2021-04-22 10:11:01",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)一季度净利降1.12%至886.19万元",
    "href": "http://stock.jrj.com.cn/2021/04/21193032418015.shtml",
    "datetime": "2021-04-21 19:30:33",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)2020年净利降10.40%至5652.54万元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2021/04/21192732418005.shtml",
    "datetime": "2021-04-21 19:27:49",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：创新产品流出道单瓣补片全球首次获批上市",
    "href": "http://stock.jrj.com.cn/2021/04/12160132357954.shtml",
    "datetime": "2021-04-12 16:01:39",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：介入肺动脉瓣及输送系统临床试验获备案",
    "href": "http://stock.jrj.com.cn/2021/03/22175632195595.shtml",
    "datetime": "2021-03-22 17:56:24",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：介入肺动脉瓣及输送系统临床试验备案",
    "href": "http://stock.jrj.com.cn/2021/03/22154932194417.shtml",
    "datetime": "2021-03-22 15:49:13",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2020年度净利5602.09万减少11.2% 研发费用增幅较大",
    "href": "http://stock.jrj.com.cn/2021/01/30065431812638.shtml",
    "datetime": "2021-01-30 06:54:55",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]佰仁医疗投资者关系活动记录",
    "href": "http://stock.jrj.com.cn/2021/01/11000031669244.shtml",
    "datetime": "2021-01-11 00:00:00",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]佰仁医疗(江苏)有限公司揭牌",
    "href": "http://stock.jrj.com.cn/2021/01/07000031647772.shtml",
    "datetime": "2021-01-07 00:00:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：程琪因个人身体原因辞去董事、董秘、财务总监职务",
    "href": "http://stock.jrj.com.cn/2020/12/11211731467299.shtml",
    "datetime": "2020-12-11 21:17:06",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：拟使用最高余额不超3.7亿元部分暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2020/12/07185231432263.shtml",
    "datetime": "2020-12-07 18:52:40",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：首次公开发行战略配售限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2020/12/01001031379143.shtml",
    "datetime": "2020-12-01 00:10:06",
    "code": "688198"
  },
  {
    "title": "佰仁医疗(688198.SH)：240万股战略配售限售股将上市流通",
    "href": "http://stock.jrj.com.cn/2020/11/30161631376480.shtml",
    "datetime": "2020-11-30 16:16:08",
    "code": "688198"
  },
  {
    "title": "佰仁医疗前三季度净利5651.07万增长18.45% 投资收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/23091131113865.shtml",
    "datetime": "2020-10-23 09:11:24",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/23001031111802.shtml",
    "datetime": "2020-10-23 00:10:11",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]宁夏中卫市委书记何健与北京佰仁医疗科技股份有限公司",
    "href": "http://stock.jrj.com.cn/2020/09/26000030853724.shtml",
    "datetime": "2020-09-26 00:00:00",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]昌平新城东区佰仁医疗二期建设项目开工仪式隆重举行",
    "href": "http://stock.jrj.com.cn/2020/09/14000030853727.shtml",
    "datetime": "2020-09-14 00:00:00",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]2020年北京辖区上市公司投资者集体接待日活动记录",
    "href": "http://stock.jrj.com.cn/2020/09/10000030853722.shtml",
    "datetime": "2020-09-10 00:00:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：公司眼科生物补片产品已在6家主流医院眼科中心全面推进临床试验",
    "href": "http://stock.jrj.com.cn/2020/08/25154130585980.shtml",
    "datetime": "2020-08-25 15:41:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2020年上半年净利3318.4万 同比增长2.96%",
    "href": "http://stock.jrj.com.cn/2020/08/19222330541601.shtml",
    "datetime": "2020-08-19 22:23:50",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：上半年实现净利润3318万元",
    "href": "http://stock.jrj.com.cn/2020/08/19191430540713.shtml",
    "datetime": "2020-08-19 19:14:00",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]佰仁医疗牵头的介入肺动脉瓣项目获科技部国家重点研发计划项目立项",
    "href": "http://stock.jrj.com.cn/2020/08/03000030853720.shtml",
    "datetime": "2020-08-03 00:00:00",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]【重磅】国产生物瓣中长期大组随访数据发表",
    "href": "http://stock.jrj.com.cn/2020/07/02000030853721.shtml",
    "datetime": "2020-07-02 00:00:00",
    "code": "688198"
  },
  {
    "title": "快讯：佰仁医疗急速拉升5.56% 主力资金净流出77.29万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30093530094090.shtml",
    "datetime": "2020-06-30 09:35:24",
    "code": "688198"
  },
  {
    "title": "快讯：佰仁医疗急速拉升5.96% 主力资金净流入744.51万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/29101030084178.shtml",
    "datetime": "2020-06-29 10:10:54",
    "code": "688198"
  },
  {
    "title": "快讯：佰仁医疗急速拉升5.96% 主力资金净流入827.84万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/29101030084171.shtml",
    "datetime": "2020-06-29 10:10:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/06/28204030072779.shtml",
    "datetime": "2020-06-28 20:40:07",
    "code": "688198"
  },
  {
    "title": "快讯：佰仁医疗急速拉升5.73% 主力资金净流入398.74万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/23094729996162.shtml",
    "datetime": "2020-06-23 09:47:11",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：研发人员数“成谜” 核心技术人员拿5.54万元年薪后辞职",
    "href": "http://stock.jrj.com.cn/2020/05/31072729803463.shtml",
    "datetime": "2020-05-31 07:27:29",
    "code": "688198"
  },
  {
    "title": "佰仁医疗在研产品眼外科生物补片完成临试备案",
    "href": "http://stock.jrj.com.cn/2020/05/22173229741236.shtml",
    "datetime": "2020-05-22 17:32:26",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/21074029727876.shtml",
    "datetime": "2020-05-21 07:40:02",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2019年净利润同比增长88% 拟10派2元",
    "href": "http://stock.jrj.com.cn/2020/04/23103829356748.shtml",
    "datetime": "2020-04-23 10:38:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗第一季度盈利896.26万同比减少31.13% 销售商品收入减少",
    "href": "http://stock.jrj.com.cn/2020/04/22104529346976.shtml",
    "datetime": "2020-04-22 10:45:11",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/22001029342283.shtml",
    "datetime": "2020-04-22 00:10:22",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/22001029342282.shtml",
    "datetime": "2020-04-22 00:10:21",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/22001029342281.shtml",
    "datetime": "2020-04-22 00:10:21",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：第一届董事会第十九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/22001029342280.shtml",
    "datetime": "2020-04-22 00:10:20",
    "code": "688198"
  },
  {
    "title": "佰仁医疗业绩快报：2019年努力开拓销售市场 净利同比增近九成",
    "href": "http://stock.jrj.com.cn/2020/02/28154228914865.shtml",
    "datetime": "2020-02-28 15:42:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗2019年盈利6261万元增长87% 控制成本支出",
    "href": "http://stock.jrj.com.cn/2020/02/27193528908389.shtml",
    "datetime": "2020-02-27 19:35:09",
    "code": "688198"
  },
  {
    "title": "佰仁医疗业绩快报：2019年净利6261万元 同比增长87.46％",
    "href": "http://stock.jrj.com.cn/2020/02/27163328907198.shtml",
    "datetime": "2020-02-27 16:33:13",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2019年净利6261万元 同比增长87%",
    "href": "http://stock.jrj.com.cn/2020/02/27162128907122.shtml",
    "datetime": "2020-02-27 16:21:05",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/02/18230028850883.shtml",
    "datetime": "2020-02-18 23:00:18",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]抗“疫”在行动!佰仁医疗——捐赠1450套防护服用于一线救治防护工作",
    "href": "http://stock.jrj.com.cn/2020/02/10000030853719.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：2019年年度业绩预增公告",
    "href": "http://stock.jrj.com.cn/2020/01/21075028710911.shtml",
    "datetime": "2020-01-21 07:50:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/01/16232028689270.shtml",
    "datetime": "2020-01-16 23:20:04",
    "code": "688198"
  },
  {
    "title": "佰仁医疗使用1600万元超募资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/01/16201328688504.shtml",
    "datetime": "2020-01-16 20:13:43",
    "code": "688198"
  },
  {
    "title": "佰仁医疗聘任李武平为公司副总经理",
    "href": "http://stock.jrj.com.cn/2020/01/16200128688451.shtml",
    "datetime": "2020-01-16 20:01:59",
    "code": "688198"
  },
  {
    "title": "佰仁医疗使用部分暂时闲置募集资金3.76亿元进行现金管理",
    "href": "http://stock.jrj.com.cn/2019/12/12084928522762.shtml",
    "datetime": "2019-12-12 08:49:42",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]佰仁医疗登陆科创板:发展势头良好 六大产品填补国内空白",
    "href": "http://stock.jrj.com.cn/2019/12/10000030853716.shtml",
    "datetime": "2019-12-10 00:00:00",
    "code": "688198"
  },
  {
    "title": "科创板卓易信息一度大涨145% 佰仁医疗涨70%临时停牌",
    "href": "http://stock.jrj.com.cn/2019/12/09140728507771.shtml",
    "datetime": "2019-12-09 14:07:09",
    "code": "688198"
  },
  {
    "title": "科创板卓易信息涨幅一度扩大至145% 佰仁医疗涨70%临时停牌",
    "href": "http://stock.jrj.com.cn/2019/12/09135528507424.shtml",
    "datetime": "2019-12-09 13:55:00",
    "code": "688198"
  },
  {
    "title": "12月9日新股提示：佰仁医疗、卓易信息上市 天迈科技中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2019/12/09080928516574.shtml",
    "datetime": "2019-12-09 08:09:04",
    "code": "688198"
  },
  {
    "title": "佰仁医疗今日上市 发行价格23.68元/股",
    "href": "http://stock.jrj.com.cn/ipo/2019/12/09080228516386.shtml",
    "datetime": "2019-12-09 08:02:45",
    "code": "688198"
  },
  {
    "title": "11月29日新股提示：久量股份上市 佰仁医疗、江苏北人中签号出炉 邮储银行公布中签率",
    "href": "http://stock.jrj.com.cn/ipo/2019/11/29082028466423.shtml",
    "datetime": "2019-11-29 08:20:13",
    "code": "688198"
  },
  {
    "title": "【兑奖啦】江苏北人网上申购中签号出炉 共20045个",
    "href": "http://stock.jrj.com.cn/ipo/2019/11/28190828464622.shtml",
    "datetime": "2019-11-28 19:08:39",
    "code": "688198"
  },
  {
    "title": "【兑奖啦】佰仁医疗、江苏北人网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2019/11/28190728464590.shtml",
    "datetime": "2019-11-28 19:07:05",
    "code": "688198"
  },
  {
    "title": "11月28日新股提示：邮储银行申购 泰和科技上市 卓易信息中签号出炉 佰仁医疗、江苏北人公布中签率",
    "href": "http://stock.jrj.com.cn/ipo/2019/11/28084928461543.shtml",
    "datetime": "2019-11-28 08:49:22",
    "code": "688198"
  },
  {
    "title": "佰仁医疗网上发行最终中签率为0.0436%",
    "href": "http://stock.jrj.com.cn/ipo/2019/11/28082528461449.shtml",
    "datetime": "2019-11-28 08:25:04",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：网上发行最终中签率为0.04356475％",
    "href": "http://stock.jrj.com.cn/ipo/2019/11/27191128459479.shtml",
    "datetime": "2019-11-27 19:11:10",
    "code": "688198"
  },
  {
    "title": "11月27日新股提示：佰仁医疗、江苏北人申购 硕世生物中签号出炉 卓易信息公布中签率",
    "href": "http://stock.jrj.com.cn/ipo/2019/11/27081828463117.shtml",
    "datetime": "2019-11-27 08:18:15",
    "code": "688198"
  },
  {
    "title": "新股提示：江苏北人、佰仁医疗今日申购",
    "href": "http://stock.jrj.com.cn/2019/11/27065828455638.shtml",
    "datetime": "2019-11-27 06:58:00",
    "code": "688198"
  },
  {
    "title": "科创板新股江苏北人、佰仁医疗11月27日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2019/11/26144728452668.shtml",
    "datetime": "2019-11-26 14:47:37",
    "code": "688198"
  },
  {
    "title": "证监会同意佰仁医疗等4家企业科创板IPO注册",
    "href": "http://stock.jrj.com.cn/kcb/2019/11/07194728367458.shtml",
    "datetime": "2019-11-07 19:47:03",
    "code": "688198"
  },
  {
    "title": "上交所：佰仁医疗、晶丰明源科创板首发过会",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/26170728034057.shtml",
    "datetime": "2019-08-26 17:07:03",
    "code": "688198"
  },
  {
    "title": "佰仁医疗 销售费用激增正常吗？",
    "href": "http://stock.jrj.com.cn/2019/08/23011428019652.shtml",
    "datetime": "2019-08-23 01:14:01",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：北京佰仁医疗科技股份有限公司科创板首次公开发行股票招股说明书（上会稿）",
    "href": "http://stock.jrj.com.cn/2019/08/15215127983592.shtml",
    "datetime": "2019-08-15 21:51:07",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：8-2 致同会计师事务所（特殊普通合伙）关于佰仁医疗第五轮审核问询函的专项说明",
    "href": "http://stock.jrj.com.cn/2019/08/13183727970856.shtml",
    "datetime": "2019-08-13 18:37:18",
    "code": "688198"
  },
  {
    "title": "佰仁医疗科创板项目状态恢复为已问询",
    "href": "http://stock.jrj.com.cn/2019/08/12174027963275.shtml",
    "datetime": "2019-08-12 17:40:10",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，北京佰仁医疗科技股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/08/12173127963183.shtml",
    "datetime": "2019-08-12 17:31:21",
    "code": "688198"
  },
  {
    "title": "佰仁医疗中止科创板上市流程 已更新上半年财务数据",
    "href": "http://stock.jrj.com.cn/2019/08/12172727963174.shtml",
    "datetime": "2019-08-12 17:27:36",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：8-2 致同会计师事务所（特殊普通合伙）关于佰仁医疗第四轮审核问询函的专项说明",
    "href": "http://stock.jrj.com.cn/2019/07/17172727853091.shtml",
    "datetime": "2019-07-17 17:27:22",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：8-1 国信证券股份有限公司与北京佰仁医疗科技股份有限公司关于第四轮审核问询函的回复",
    "href": "http://stock.jrj.com.cn/2019/07/17172727853093.shtml",
    "datetime": "2019-07-17 17:27:22",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，北京佰仁医疗科技股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/07/17172627853092.shtml",
    "datetime": "2019-07-17 17:26:19",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：致同会计师事务所（特殊普通合伙）关于佰仁医疗第三轮审核问询函的专项说明",
    "href": "http://stock.jrj.com.cn/2019/06/17171727715284.shtml",
    "datetime": "2019-06-17 17:17:04",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：国信证券股份有限公司与北京佰仁医疗科技股份有限公司关于第三轮审核问询函的回复",
    "href": "http://stock.jrj.com.cn/2019/06/17171727715283.shtml",
    "datetime": "2019-06-17 17:17:04",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：北京海润天睿律师事务所关于佰仁医疗首次公开发行股票并在科创板上市的补充法律意见书（三）",
    "href": "http://stock.jrj.com.cn/2019/06/17171727715280.shtml",
    "datetime": "2019-06-17 17:17:04",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，北京佰仁医疗科技股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/06/17171627715282.shtml",
    "datetime": "2019-06-17 17:16:03",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：国信证券股份有限公司与北京佰仁医疗科技股份有限公司关于第二轮审核问询函的回复",
    "href": "http://stock.jrj.com.cn/2019/05/30193027643150.shtml",
    "datetime": "2019-05-30 19:30:10",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：北京海润天睿律师事务所关于佰仁医疗首次公开发行股票并在科创板上市的补充法律意见书（二）",
    "href": "http://stock.jrj.com.cn/2019/05/30193027643149.shtml",
    "datetime": "2019-05-30 19:30:10",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，北京佰仁医疗科技股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/05/30192627643148.shtml",
    "datetime": "2019-05-30 19:26:19",
    "code": "688198"
  },
  {
    "title": "佰仁医疗：创始人夫妇持股集中 员工激励方案值得探讨",
    "href": "http://stock.jrj.com.cn/2019/05/24070927617034.shtml",
    "datetime": "2019-05-24 07:09:12",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：国信证券股份有限公司与北京佰仁医疗科技股份有限公司关于审核问询函的回复",
    "href": "http://stock.jrj.com.cn/2019/05/10175527554901.shtml",
    "datetime": "2019-05-10 17:55:21",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：致同会计师事务所（特殊普通合伙）关于佰仁医疗审核问询函的专项说明",
    "href": "http://stock.jrj.com.cn/2019/05/10175527554902.shtml",
    "datetime": "2019-05-10 17:55:21",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：北京海润天睿律师事务所关于佰仁医疗首次公开发行股票并在科创板上市的补充法律意见书",
    "href": "http://stock.jrj.com.cn/2019/05/10175527554903.shtml",
    "datetime": "2019-05-10 17:55:21",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，北京佰仁医疗科技股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/05/10174127554826.shtml",
    "datetime": "2019-05-10 17:41:15",
    "code": "688198"
  },
  {
    "title": "科创板已受理企业佰仁医疗、西部超导获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/04/25191727483350.shtml",
    "datetime": "2019-04-25 19:17:00",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，北京佰仁医疗科技股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/04/25191127483315.shtml",
    "datetime": "2019-04-25 19:11:09",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]一切为了中国“心”的重生",
    "href": "http://stock.jrj.com.cn/2019/04/19000030853715.shtml",
    "datetime": "2019-04-19 00:00:00",
    "code": "688198"
  },
  {
    "title": "[佰仁医疗]从“科技芯”到“健康心”──记北京佰仁医疗科技有限公司董事长金磊",
    "href": "http://stock.jrj.com.cn/2019/04/19000030853717.shtml",
    "datetime": "2019-04-19 00:00:00",
    "code": "688198"
  },
  {
    "title": "佰仁医疗豪赌科创板：“飞检”曾被查出缺陷 毛利率91%显著超同行",
    "href": "http://stock.jrj.com.cn/2019/04/17110327414722.shtml",
    "datetime": "2019-04-17 11:03:00",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：进军科创板，北京佰仁医疗科技股份有限公司申请已获上交所受理",
    "href": "http://stock.jrj.com.cn/2019/04/16165627407405.shtml",
    "datetime": "2019-04-16 16:56:44",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：北京佰仁医疗科技股份有限公司科创板首次公开发行股票招股说明书（申报稿）",
    "href": "http://stock.jrj.com.cn/2019/04/15190927398646.shtml",
    "datetime": "2019-04-15 19:09:15",
    "code": "688198"
  },
  {
    "title": "上交所受理北京佰仁医疗、江西金达莱环保科创板上市申请",
    "href": "http://stock.jrj.com.cn/2019/04/15182127398222.shtml",
    "datetime": "2019-04-15 18:21:00",
    "code": "688198"
  },
  {
    "title": "上交所受理佰仁医疗、金达莱环保的科创板上市申请",
    "href": "http://stock.jrj.com.cn/2019/04/15182027398208.shtml",
    "datetime": "2019-04-15 18:20:28",
    "code": "688198"
  },
  {
    "title": "每经小强快讯：进军科创板，北京佰仁医疗科技股份有限公司申请已获上交所受理",
    "href": "http://stock.jrj.com.cn/2019/04/15181627398153.shtml",
    "datetime": "2019-04-15 18:16:16",
    "code": "688198"
  }
]